On September 27, 2021 KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported that Travis C. Mickle, Ph.D., President and Chief Executive Officer of KemPharm, will present at the Benzinga Healthcare Small Cap Conference taking place September 29-30, 2001 (Press release, KemPharm, SEP 27, 2021, View Source [SID1234590316]). The presentation will be available on the conference’s virtual platform to all registered attendees.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the presentation are as follows:

Event: Benzinga Healthcare Small Cap Conference
Date: September 30, 2021
Time: 4:20 p.m., ET
Registration: View Source

Following the conclusion of the event, a recording of Dr. Mickle’s presentation will be available under "Events & Presentations" in the Investor Relations section of the Company’s website at View Source